Profile
ACGN VRTX REGN SGEN ARGX ALNY
Company Name Aceragen, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $3.24M $128.84B $64.28B $43.15B $39.39B $33.74B
Employees 0.03K 6.10K 15.16K 3.26K 1.60K 2.23K
CEO Mr. John C. Taylor Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc. Dr. Yvonne L. Greenstreet M.B.A., M.D.
Ratings
ACGN VRTX REGN SGEN ARGX ALNY
Quant Rating Score 2 4 3 3 1
Quant Rating Sell Buy Neutral Neutral Strong Sell
Trading
ACGN VRTX REGN SGEN ARGX ALNY
Last Close $0.3849 $429.6 $547.67 $228.74 $569.12 $258.35
High 52 $0.38 $516.74 $1201.76 $228.74 $671.75 $296.75
Low 52 $0.38 $396.64 $546.39 $228.74 $356.01 $146.93
Price vs. 52 Week High 1.29 % -16.86 % -54.43 % 0 % -15.28 % -12.94 %
Price vs. 52 Week Low 1.29 % 8.31 % 0.23 % 0 % 59.86 % 75.83 %
Total Return
ACGN VRTX REGN SGEN ARGX ALNY
1 Month Return 0 % -10.93 % -4.95 % 0 % 0.94 % 6.21 %
3 Month Return 0 % -8.46 % -22.81 % 0 % -11.99 % -6.46 %
6 Month Return 0 % -16.86 % -33.89 % 0 % -4.51 % -6.88 %
9 Month Return 0 % -8.29 % -51.59 % 0 % 6.38 % -4.14 %
YTD Return 0 % 6.68 % -23.12 % 0 % -7.46 % 9.79 %
1 Year Return 0 % 2.53 % -43.42 % 0 % 48.77 % 70.67 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACGN VRTX REGN SGEN ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.15 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - -1.65 % 3.85 % -2.27 % -44.32 % -1.49 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
ACGN VRTX REGN SGEN ARGX ALNY
Gross Profit Margin TTM 100 % 86.09 % 84.94 % 72.37 % 46.33 % 86.01 %
Return on Assets TTM -23.1 % -2.38 % 11.98 % -11.76 % 13.45 % -6.4 %
Return on Equity TTM -68.32 % -3.28 % 14.77 % -16.53 % 16.83 % -509.33 %
Return on Capital Employed TTM -34.91 % -1.3 % 11.35 % -16.87 % -0.31 % -3.68 %
Net Income Per EBT TTM 78.71 % -215.53 % 90.27 % 100.55 % 25990.14 % 75.89 %
EBT Per Ebit TTM 106.69 % -100.69 % 129.3 % 94.01 % -18.79 % 308.03 %
EBIT Per Revenue TTM -572.15 % -2.24 % 27.37 % -36.09 % -0.77 % -4.91 %
Cash Flow To Debt Ratio TTM -4374.11 % -28.16 % 146.15 % -185.98 % -201.37 % -3.47 %
Receivables Turnover TTM 1.16 6.84 2.53 1.98 2.46 5.62
Payables Turnover TTM - 3.71 3.01 1.54 1.83 3.37
Inventory Turnover TTM - 1.27 0.66 0.65 2.93 5.01
Fixed Asset Turnover TTM 893.75 % 425.82 % 300.07 % 256.83 % 5106.8 % 337.41 %
Asset Turnover TTM 4.81 % 48.84 % 37.52 % 34.46 % 35.83 % 55.72 %
Operating Cash Flow Per Share TTM -7.52 -1.91 37.05 -1.12 -1.07 -0.35
Free Cash Flow Per Share TTM -7.52 -3.07 28.3 -1.62 -1.09 -0.58
Cash Per Share TTM 369.79 % 2375.11 % 7825.12 % 657.5 % 4597.04 % 2024.29 %
Operating Cash Flow Sales Ratio TTM -503.81 % -4.48 % 28.06 % -16.85 % -3.54 % -1.92 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 160.43 % 76.4 % 144.14 % 102.26 % 167.11 %
Cash Flow Coverage Ratios TTM -4374.11 % -28.16 % 146.15 % -185.98 % -201.37 % -3.47 %
Price To Free Cash Flows Ratio TTM -0.13 -163.02 21.29 -141.85 -505.86 -447.57
Price To Operating Cash Flows Ratio TTM -0.05 -261.97 16.35 -203.89 -601.06 -745.64
Price Cash Flow Ratio TTM -0.05 -261.97 16.35 -203.89 -601.06 -745.64
Income Statement (TTM)
ACGN VRTX REGN SGEN ARGX ALNY
Revenue $0B $11.02B $14.2B $1.96B $2.19B $2.25B
Gross Profit $0B $9.49B $12.23B $1.55B $1.96B $1.92B
Gross Profit Ratio 100% 86.11% 86.13% 79.1% 89.62% 85.62%
EBITDA $-0.01B $0.48B $5.32B $-0.62B $0B $-0.18B
Net Income $-0.02B $-0.54B $4.41B $-0.61B $0.83B $-0.28B
EPS Diluted -7.17 -2.08 38.34 -3.3 12.78 -2.16
Balance Sheet (MRQ)
ACGN VRTX REGN SGEN ARGX ALNY
Long Term Debt $0B $1.66B $1.98B $0.04B $0.03B $0B
Total Liabilities $0.06B $6.12B $8.41B $0.87B $0.7B $4.17B
Total Equity $0.04B $16.41B $29.35B $2.8B $5.5B $0.07B
Total Investments $0B $6.65B $15.42B $1.42B $1.93B $1.73B
Total Debt $0B $1.75B $2.7B $0.04B $0.04B $1.3B
Total Assets $0.1B $22.53B $37.76B $3.67B $6.2B $4.3B
Cash Flow Statement (TTM)
ACGN VRTX REGN SGEN ARGX ALNY
Net Income $-0.02B $-0.54B $4.41B $-0.61B $0.8B $-0.28B
Inventory $0B $-0.52B $-0.62B $-0.23B $-0.09B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.02B $-0.49B $4.42B $-0.45B $-0.08B $-0.01B
Capital Expenditure $0B $-0.3B $-0.76B $-0.08B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.375
ABCL AbCellera Biologics Inc. 2.02
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.265
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 0.9802
ABPWW 0.02
ABSI Absci Corporation 2.74
ABUS Arbutus Biopharma Corporation 3.22
ABVC ABVC BioPharma, Inc. 1.21
ABVX Abivax SA American Depositary Shares 6.7
ACAD ACADIA Pharmaceuticals Inc. 17.44
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.608
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.34
ACIU AC Immune SA 1.68
ACLX Arcellx, Inc. 57.52
ACRV Acrivon Therapeutics, Inc. Common Stock 1.175
ETFs With Exposure to ACGN
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 277.95
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 123.37
VXF Vanguard Extended Market Index Fund 0 177.3
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 134.56
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 134.57
VEMPX Vanguard Extended Market Index InstlPlus 0 332.06
Unlock